235 related articles for article (PubMed ID: 20381170)
1. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of divalproate in all forms of mania and the broader bipolar spectrum: many questions, few answers.
Bowden C
J Affect Disord; 2004 Apr; 79 Suppl 1():S9-14. PubMed ID: 15121342
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H
J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
[TBL] [Abstract][Full Text] [Related]
4. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
[TBL] [Abstract][Full Text] [Related]
6. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
7. [Predictors of prophylactic response to lithium].
Rohayem J; Baylé JF; Richa S
Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
[TBL] [Abstract][Full Text] [Related]
8. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
10. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
11. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
[TBL] [Abstract][Full Text] [Related]
12. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
14. Treatment-refractory bipolar disorder: classification to aid in clinical management.
Gajwani P
Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
16. Is adjunctive open-label zonisamide effective for bipolar disorder?
Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial.
Bowden CL; Mosolov S; Hranov L; Chen E; Habil H; Kongsakon R; Manfredi R; Lin HN
Int Clin Psychopharmacol; 2010 Mar; 25(2):60-7. PubMed ID: 20101186
[TBL] [Abstract][Full Text] [Related]
18. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
Friedman SD; Dager SR; Parow A; Hirashima F; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
Biol Psychiatry; 2004 Sep; 56(5):340-8. PubMed ID: 15336516
[TBL] [Abstract][Full Text] [Related]
19. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
20. Combination lithium and divalproex sodium in pediatric bipolarity.
Findling RL; McNamara NK; Gracious BL; Youngstrom EA; Stansbrey RJ; Reed MD; Demeter CA; Branicky LA; Fisher KE; Calabrese JR
J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):895-901. PubMed ID: 12874490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
